{
    "nctId": "NCT03297125",
    "officialTitle": "Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI",
    "inclusionCriteria": "* Newly diagnosed glioblastoma (GBM), World Health Organization (WHO) grade IV.\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Optune compliance \\< 75%; they would be excluded from the final analyses.\n* History of craniectomy or significant skull defect (contraindication to Optune).\n* Active implantable medical device (e.g., deep brain stimulator (DBS), spinal cord stimulator, pacemaker, defibrillator, vagus nerve stimulator, programmable shunt).\n* Karnofsky Performance Status (KPS) \\< 60."
}